Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TELEFLEX INC Capital/Financing Update 2010

Aug 4, 2010

30968_rns_2010-08-04_03bcf52b-7b51-4ab6-a677-c29d331f416e.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

FWP 1 w79423fwp.htm FWP fwp PAGEBREAK

Filed pursuant to Rule 433 under the Securities Act of 1933 Issuer Free Writing Prospectus dated August 3, 2010 Relating to Preliminary Prospectus Supplement dated August 2, 2010 Registration Statement No. 333-168464

PRICING TERM SHEET

Dated August 3, 2010 to the

Preliminary Prospectus Supplement Referred to Below

Teleflex Incorporated

Offering of

$350,000,000 principal amount of 3.875% Convertible Senior Subordinated Notes due 2017

The information in this pricing term sheet relates only to the Convertible Senior Subordinated Notes offering and should be read together with (i) the preliminary prospectus supplement dated August 2, 2010 relating to the Convertible Senior Subordinated Notes offering, including the documents incorporated by reference therein, and (ii) the accompanying prospectus dated August 2, 2010, each filed with the Securities and Exchange Commission (the “SEC”).

Issuer: Teleflex Incorporated, a Delaware corporation.
Ticker/Exchange for Common Stock: TFX/The New York Stock Exchange (“NYSE”)
Securities Offered: 3.875% Convertible Senior Subordinated Notes due 2017 (the
“Notes”).
Aggregate Principal Amount
Offered: $350,000,000 aggregate principal amount of Notes.
Underwriters’ Option to
Purchase Additional Notes: Up to $50,000,000 principal amount of additional Notes.
Net Proceeds of the Offering: Approximately $338.6 million (or approximately $387.2
million if the underwriters exercise their option to
purchase additional notes in full), after deducting the
underwriters’ discounts and commissions and estimated
offering expenses payable by the Issuer.
Convertible Note Hedge
Transactions and Warrant
Transactions: Approximately $25.0 million of the net proceeds from the
offering will be used to pay the cost of the convertible
note hedge transactions (after such cost is partially
offset by the proceeds to us from the sale of the
warrants). If the underwriters exercise their option to
purchase additional notes, the notional size of the
convertible note hedge transactions and the warrant
transactions will be automatically increased in a manner
proportionate to the increase in the principal amount of
the notes being sold in the offering. In such event, the
Issuer intends to use a proportionate portion of the net
proceeds from the sale of such additional Notes (together
with proceeds to the Issuer from the increase in the size
of the warrant transactions) to fund the additional cost of
the increased convertible note hedge transactions. The
strike price of the warrant transactions is $74.648
(subject to customary anti-dilution adjustments), which
represents a 40% premium over the Closing Stock Price.

Folio 1 /Folio

PAGEBREAK

| Maturity Date: | August 1, 2017, unless earlier converted or repurchased by
the Issuer at the holder’s option upon a fundamental
change. |
| --- | --- |
| Annual Interest Rate: | 3.875% per annum, accruing from the Settlement Date. |
| Interest Payment Dates: | Each February 1 and August 1, beginning on February 1, 2011. |
| Interest Payment Record Dates: | January 15 and July 15. |
| Public Offering Price: | 100% |
| Closing Stock Price: | $53.32 per share of the Issuer’s common stock on the NYSE
as of August 3, 2010. |
| Conversion Premium: | Approximately 15% above the Closing Stock Price. |
| Conversion Price: | Approximately $61.32 per share of the Issuer’s common
stock, subject to adjustment. |
| Conversion Rate: | 16.3084 shares of the Issuer’s common stock per $1,000
principal amount of the Notes, subject to adjustment. |
| Joint Book-Running Managers: | Goldman, Sachs & Co., Jefferies & Company, Inc., Morgan
Stanley & Co. Incorporated, Merrill Lynch, Pierce, Fenner &
Smith Incorporated and J.P. Morgan Securities Inc. |
| Pricing Date: | August 3, 2010 |
| Expected Settlement Date: | August 9, 2010 |
| CUSIP/ISIN Number: | 879369AA42 / US879369AA42 |
| Pro Forma Ratio of Earnings
to Fixed Charges: | Assuming the Refinancing Transactions were completed as of
January 1, 2009, the pro forma ratio of earnings to
fixed charges for the six months ended June 27, 2010 is
3.1. |
| Borrowing Capacity: | As of June 27, 2010, on an as adjusted basis after giving
effect to the Refinancing Transactions, the Issuer would
have approximately $345.4 million of borrowing capacity,
consisting of $311.0 million of aggregate borrowing
capacity under the Issuer’s revolving credit facility and
$34.4 million of borrowing capacity under the Issuer’s
accounts receivable securitization facility. |
| Adjustment to Conversion Rate
Upon Conversion Upon a
Make-Whole Fundamental
Change: | The following table sets forth the number of additional
shares of the Issuer’s common stock by which the conversion
rate will be increased per $1,000 principal amount of
Convertible Senior Subordinated Notes for conversions in
connection with a make-whole fundamental change based on
the stock price and effective date of such make-whole
fundamental change: |

Folio 2 /Folio

PAGEBREAK

Stock Price
Effective
Date $53.32 $55.00 $60.00 $65.00 $70.00 $80.00 $90.00 $100.00 $120.00 $140.00 $160.00 $180.00
August 9, 2010 2.4462 2.3988 1.8223 1.4229 1.1561 0.7968 0.5412 0.3503 0.1375 0.0542 0.0248 0.0075
August 1, 2011 2.4462 2.2671 1.6831 1.2788 1.0186 0.7023 0.4689 0.2975 0.1053 0.0337 0.0093 0.0000
August 1, 2012 2.4186 2.1625 1.5680 1.1563 0.8944 0.6024 0.4000 0.2501 0.0824 0.0237 0.0042 0.0000
August 1, 2013 2.3672 2.1010 1.4760 1.0431 0.7621 0.5051 0.3283 0.2038 0.0610 0.0135 0.0000 0.0000
August 1, 2014 2.3591 2.0756 1.4063 0.9483 0.6473 0.3811 0.2430 0.1443 0.0353 0.0012 0.0000 0.0000
August 1, 2015 2.3794 2.0643 1.3271 0.8247 0.4993 0.2336 0.1322 0.0626 0.0000 0.0000 0.0000 0.0000
August 1, 2016 2.4462 2.0944 1.2521 0.7020 0.3644 0.1198 0.0638 0.0228 0.0000 0.0000 0.0000 0.0000
August 1, 2017 2.4462 1.8734 0.3582 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000

The exact stock prices and effective dates may not be set forth in the table above, in which case:

| • | if the stock price is between two stock prices in the table or the effective date is
between two effective dates in the table, the number of additional shares will be
determined by a straight-line interpolation between the number of additional shares set
forth for the higher and lower stock prices and the earlier and later effective dates,
as applicable, based on a 365-day year; |
| --- | --- |
| • | if the stock price is greater than $180.00 per share (subject to adjustment in the
same manner as the stock prices set forth in the column headings of the table above),
the conversion rate will not be increased; and |
| • | if the stock price is less than $53.32 per share (subject to adjustment in the same
manner as the stock prices set forth in the column headings of the table above), the
conversion rate will not be increased. |

Notwithstanding the foregoing, in no event will the conversion rate exceed 18.7546 shares per $1,000 principal amount of notes, subject to adjustments in the same manner as the conversion rate as set forth under “Description of Notes—Conversion Rights—Conversion Rate Adjustments” in the preliminary prospectus supplement dated August 2, 2010.

Folio 3 /Folio

PAGEBREAK

Capitalization

The following table sets forth Issuer’s cash and cash equivalents and capitalization as of June 27, 2010:

• on an actual basis; and
• on an as adjusted basis to give effect to the Refinancing Transactions.

This table should be read in conjunction with the information set forth under the “Use of Proceeds” section and the “Description of Other Indebtedness” section included in the preliminary prospectus supplement and the Issuer’s consolidated financial statements and the notes thereto incorporated by reference in the preliminary prospectus supplement and accompanying prospectus.

As of June 27, 2010 — Actual As Adjusted (1)
(Dollars in thousands)
Cash and cash equivalents $ 287,129 $ 171,922
Current borrowings:
Accounts receivable securitization facility (2) $ 39,700 $ 39,700
Other (3) $ 1,764 $ 1,764
Total current borrowings $ 41,464 $ 41,464
Long-term debt:
Credit Facilities:
Term loan facility due 2012 (4) $ 600,000 $ 36,123
Term loan facility due 2014 (4) — 363,877
Revolving credit facility due 2012 — 843
Revolving credit facility due 2014 — 9,157
Existing 2007 Senior Notes:
7.62% Series A Senior Notes due 2012 130,000 —
7.94% Series B Senior Notes due 2014 40,000 —
Floating Rate Series C Senior Notes due 2012 26,600 —
Existing 2004 Senior Notes (5) :
6.66% Series 2004-1 Tranche A Senior Notes due 2011 145,000 145,000
7.14% Series 2004-1 Tranche B Senior Notes due 2014 96,500 96,500
7.46% Series 2004-1 Tranche C Senior Notes due 2016 90,100 90,100
3.875% Convertible Senior Subordinated Notes due 2017 (6) — 350,000
Unamortized discount on 3.875% Convertible Senior Subordinated
Notes due 2017 (6) — (73,263 )
Total long-term debt $ 1,128,200 $ 1,018,337
Total debt $ 1,169,664 $ 1,059,801
Common shareholders’ equity:
Common shares, $1 par value (7) 42,191 42,191
Additional paid-in capital (6) 289,319 320,047
Retained earnings 1,502,831 1,482,834
Accumulated other comprehensive income (121,188 ) (121,188 )
Less: Treasury stock, at cost (2,264,190 shares) (135,921 ) (135,921 )
Total common shareholders’ equity $ 1,577,232 $ 1,587,963
Total capitalization $ 2,746,896 $ 2,647,764

Folio 4 /Folio

PAGEBREAK

| (1) | For purposes of these calculations, the as adjusted information assumes that the
prepayment make-whole amount included in the aggregate prepayment purchase price of the Existing
2007 Senior Notes equals approximately $27.6 million, based on applicable interest rates as of
August 2, 2010; the actual amount of the prepayment make-whole amount will be calculated using
applicable interest rates on the second business day preceding the prepayment date. In addition,
the as adjusted information assumes that accrued and unpaid interest equals approximately $4.9
million. |
| --- | --- |
| (2) | The unused borrowing capacity under Issuer’s accounts receivable securitization facility was
$34.4 million on an actual basis and $34.4 million on an adjusted basis. |
| (3) | Other current borrowings consist of outstanding indebtedness under a short-term working capital
credit facility supporting an operating subsidiary in China. |
| (4) | Aggregate unused borrowing capacity under Issuer’s revolving credit facility was $297.8 million
on an actual basis and $311.0 million on an as adjusted basis. |
| (5) | The interest rates are effective as of June 28, 2010. |
| (6) | In accordance with ASC 470-20, the fair value of the feature to convert the debt into common
stock is reported as a component of stockholders’ equity. Upon issuance of the notes, the debt will
be reported at a discount to the face amount resulting in a decrease in the amount of debt with an
increase in equity reported in Issuer’s financial statements. Under GAAP, the amount of debt
reported will accrete up to the face amount over the expected term of the debt. The determination
of the fair values of the debt and equity components has been estimated but is subject to change
based upon the completion of Issuer’s analysis of non-convertible debt interest rates. Issuer
currently estimates that the fair value of the feature to convert the debt into common stock which
will be reported as unamortized discount on the notes being offered is equal to approximately $73.3
million on a pre-tax basis; this amount will be reported, on an after-tax basis, as an increase to
additional paid-in capital on an as adjusted basis. ASC 470-20 does not affect the actual amount
that Issuer is required to repay. In addition, additional paid-in capital is reduced as a result of
the net cost of the convertible note hedge transactions and warrant transactions, which is
approximately $25.0 million on a pre-tax basis; this amount will be reported on an after-tax basis
on an as adjusted basis. |
| (7) | There are 200,000,000 authorized shares of Issuer’s common stock, of which 39,927,082 shares
were issued and outstanding as of July 14, 2010 on an actual and as adjusted basis. This amount
does not include (i) the shares of Issuer’s common stock issuable upon conversion of the notes
being offered hereby if Issuer elects to satisfy its conversion obligation by physical settlement
or combination settlement; (ii) the shares of Issuer’s common stock issuable under the warrant
transactions being entered into concurrently with this offering; (iii) 2,475,030 shares of Issuer’s
common stock issuable upon
exercise of outstanding stock options granted under Issuer’s 2000 stock compensation plan (the
“2000 Plan”) and Issuer’s 2008 stock incentive plan (the “2008 Plan”); (iv) 421,871 shares of
Issuer’s common stock issuable upon vesting of outstanding restricted stock awards under the 2000
Plan; (v) 1,724,910 shares of Issuer’s common stock reserved for issuance under the 2000 Plan and
the 2008 Plan; and (vi) approximately 20,000 shares to be distributed from the deferred
compensation plan. |

Folio 5 /Folio

PAGEBREAK

The Issuer has filed a registration statement (including the preliminary prospectus supplement dated August 2, 2010 and an accompanying prospectus dated August 2, 2010) with the SEC, for the offering to which this communication relates. Before you invest, you should read the relevant preliminary prospectus supplement, the accompanying prospectus and the other documents the Issuer has filed with the SEC for more complete information about the Issuer and the offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, copies may be obtained from Goldman, Sachs & Co., Attn: Prospectus Department, Goldman, Sachs & Co. at 200 West Street, New York, NY 10282, (866) 471-2526 or emailing [email protected], Jefferies & Company, Inc. at 520 Madison Avenue, 12th Floor, New York, NY 10022, Attention: Equity Syndicate Prospectus Department (877) 547-6340 or emailing [email protected], Morgan Stanley & Co. Incorporated at 180 Varick Street, 2nd Floor, New York, NY 10014, Attention: Prospectus Department, (866) 718-1649 or by emailing [email protected], BofA Merrill Lynch at 4 World Financial Center, New York, NY 10080, Attention: Prospectus Department or emailing [email protected] or J.P. Morgan Securities Inc. at 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245, Attention: Prospectus Library.

Folio 6 /Folio